There were no differences in relief from mild-to-moderate COVID-19 symptoms for patients on ivermectin versus placebo, according to the ongoing ACTIV-6 trial. Among >1,000 vaccinated…
Read More
A monovalent mRNA booster dose offered “limited” protection against COVID-related hospitalizations from the currently circulating Omicron variants, a CDC analysis found, likely due to the…
Matthew T. Osborne, Samuel S. Malloy, Erik C. Nisbet, Robert M. Bond & Joseph H. Tien Scientific Reports volume 12, Article number: 9832 (2022) Cite this article Metricsdetails Abstract Understanding how different…
Summary: Exposure to radicalized content online, both active and passive, was associated with a more meaningful relationship with radicalization. Source: Wiley A recent analysis in Campbell Systematic Reviews examined…
Support our mission - ad-free browsing & exclusive content.
If you value our work, consider becoming a member.
New membership plans available.
Every contribution counts